Showing results (6121-6130 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 7, 2012
Estrogen receptor beta in cancer: an attractive target for therapyDaniela Gallo, Ilaria De Stefano, Maria Grazia Prisco, et al.Current Pharmaceutical Design|March 7, 2012
Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinationsMaha Elnaggar, Elisa Giovannetti, Godefridus J PetersCurrent Pharmaceutical Design|March 7, 2012
Chemoradiotherapy of human tumors: novel approaches from nanomedicineMichael Edward Werner, Michael Bonner Foote, Andrew Zhuang WangCurrent Pharmaceutical Design|January 28, 2012
The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorderKonstantinos N FountoulakisCurrent Pharmaceutical Design|March 8, 2012
The architectural organization of human stem cell cycle regulatory machineryGary S Stein, Janet L Stein, Andre van J Wijnen, et al.Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.Current Pharmaceutical Design|February 28, 2012
Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapyWilliam M Mellana, Wilbert S Aronow, Chandrasekar Palaniswamy, et al.Current Pharmaceutical Design|February 28, 2012
Inflammation and vascular responses to acute mental stress: implications for the triggering of myocardial infarctionNicola J Paine, Jos A Bosch, Jet J C S Veldhuijzen Van ZantenCurrent Pharmaceutical Design|February 28, 2012
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and researchArmen Yuri Gasparyan, Lilit Ayvazyan, Giuseppe Cocco, et al.Current Pharmaceutical Design|March 1, 2012
Cytokine network: new targeted therapy for pancreatic cancerYoichi Matsuo, Hiromitsu Takeyama, Sushovan GuhaPageof 1,008